Integra Lifesciences Holdings's Revenue in the fiscal year 2025 $ 1,635.25 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2024 $ 1,610.53 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2023 $ 1,541.57 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2022 $ 1,557.67 millions
Integra Lifesciences Holdings's Revenue in the fiscal year 2021 $ 1,542.45 millions
IART Revenue third quarter 2026 Y/Y Growth Comment
Integra Lifesciences Holdings Corp reported Revenue growth of 2.27% year on year in the third quarter 2026, to $ 411.18 millions, this is lower than Integra Lifesciences Holdings Corp's recent average Revenue growth of 6.12%.
Looking into third quarter 2026 results within Medical Equipment & Supplies industry 131 other companies have achieved higher Revenue growth. While Integra Lifesciences Holdings Corp' s Revenue increase of 2.27% ranks overall at the positon no. 2723 in the third quarter 2026.
In the III. Quarter 2026 Integra Lifesciences Holdings Corp disclosed decrease in Revenue from the second quarter by -1.81% to $ 411.18 millions, from $ 418.76 millions achived in the previous reporting period.
But that's not important problem, as Integra Lifesciences Holdings's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 41 other companies have achieved higher Revenue quarter on quarter growth. While Integra Lifesciences Holdings's Revenue growth quarter on quarter, overall rank is 1020.
In the III. Quarter 2026 Integra Lifesciences Holdings Corp disclosed decrease in Revenue from the second quarter by -1.81% to $ 411.18 millions, from $ 418.76 millions achived in the previous reporting period.
But that's not important problem, as Integra Lifesciences Holdings's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 41 other companies have achieved higher Revenue quarter on quarter growth. While Integra Lifesciences Holdings's Revenue growth quarter on quarter, overall rank is 1020.
Integra Lifesciences Holdings's 12 Months Revenue Growth Year on Year
With the quarterly Revenue reported in the Sep 30 2026 period, Integra Lifesciences Holdings's cumulative twelve months Revenue were $ 1,657 millions, company would post below average annual Revenue growth of 0.55% year on year, if the fiscal year would end at Sep 30 2026. A slow-down in the Integra Lifesciences Holdings's Revenue growth from the 418.76% growth in Jun 30 2026.
In the Healthcare sector 325 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 2246.
With the quarterly Revenue reported in the Sep 30 2026 period, Integra Lifesciences Holdings's cumulative twelve months Revenue were $ 1,657 millions, company would post below average annual Revenue growth of -11.65% year on year, if the fiscal year would end at Sep 30 2026. A slow-down in the Integra Lifesciences Holdings's Revenue growth from the 418.76% growth in Jun 30 2026.
In the Healthcare sector 325 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1102 to 2246.
About Integra Lifesciences Holdings Revenue Growth Rates (IART), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
3.95%